+ HEALTH Aims Intramuscular fat (IMF) is increasingly recognized as a marker of ectopic adiposity and adverse cardiome…+ HEALTH Periapical lesions are challenging to detect on intraoral radiographs because of anatomical superimposition a…± HEALTH Ultrasound imaging is an indispensable diagnostic tool, yet its profound reliance on operator expertise inher…+ HEALTH Objectives We adapted the individualized polysocial risk score (iPsRS), a machine learning model originally d…± HEALTH Melioidosis is a life-threatening infectious disease caused by Burkholderia pseudomallei ( Bp ). Rapid diagno…+ HEALTH Classification is a core machine learning task, and ensemble voting methods are widely used to improve predic…+ CLIMATE Microplastic (MP) pollution poses escalating environmental risks, demanding efficient and reproducible tools…± HEALTH Medicinal chemistry sits at the center of modern drug discovery, yet translating molecular designs into appro…
TruaceTracing the truth around AIWednesday, August 26, 2026
Subscribe
Health·G Space·Evidence-backed gain·Published 2026-08-26

Tissue-Agnostic Cellular Morphometric Biomarkers for Risk-Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers

Abstract: While precision oncology increasingly adopts tissue-agnostic paradigms, current strategies remain heavily reliant on molecular alterations, with limited relevance to early-stage cancers and precancerous lesion management. Here we present an unsupervised and interpretable artificial intelligence framework that defines tissue-agnostic cellular morphometric biomarkers (CMBs) capturing conserved tumor microenvironment (TME) architectures associated with cancer progression across gastrointestinal (GI) organs. Discove…

TRV-2026-0890Peer-reviewedPermanent record — cite & verify
Tissue-Agnostic Cellular Morphometric Biomarkers for Risk-Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers

United States Navy Medical News Letter Vol. 20, No. 12, 26 December 1952 by U.S. Navy. Bureau of Medicine and Surgery. Public domain

The quick read

Researchers developed an unsupervised, interpretable AI framework to define tissue-agnostic cellular morphometric biomarkers that capture conserved tumor microenvironment organization across gastrointestinal organs. Discovered in colorectal cancer slides and validated in gastric and esophageal cancers in a 2,602-patient multi-center cohort, a 13-marker signature showed prognostic value and enabled risk stratification of precancerous lesions and early-stage cancers.

The ability to stratify precancerous and early-stage lesions using routine histology could shift management toward individualized surveillance intervals and tailored interventions without relying solely on molecular testing. Remaining questions include prospective clinical utility, generalizability beyond the studied GI sites and centers, and integration into pathology workflows.

Main points
  • Unsupervised and interpretable AI framework defined tissue-agnostic cellular morphometric biomarkers capturing conserved tumor microenvironment architectures.
  • Discovery from colorectal cancer whole-slide images, validated in gastric and esophageal malignancies in multi-center cohort of 2,602 patients.
  • Integrative bulk and single-cell RNA sequencing and immunohistochemistry showed CMBs correspond to immune-excluded and stromal-dominant architectures.
Gain

An unsupervised AI framework discovered a 13-marker cellular morphometric signature from colorectal whole-slide images that transferred to gastric and esophageal cancers and enabled risk stratification of precancerous lesions and early-stage cancers to guide surveillance and intervention.

The rundown

The study used colorectal cancer whole-slide images for discovery and extended validation to gastric and esophageal malignancies, reporting a 13-CMB signature with cross-GI transferability in 2,602 patients across multiple centers.

Authors position the approach as addressing an unmet need where molecular profiling is often impractical for early-stage disease, linking morphometric patterns to biologically interpretable TME states via RNA sequencing and immunohistochemistry.

Sources

Reader signal

How should this claim be treated?

The debate